Accelsiors is a global, full-service clinical research organization delivering end-to-end trial solutions under one roof. For over 20 years, we’ve supported biopharma with scientific, regulatory, legal, and operational expertise, driving efficient, high-quality clinical development worldwide.
Products, services, technology
Accelsiors provides global, full-service clinical research solutions under one roof, including CRO services, clinical trial design and management, regulatory and scientific advisory, functional service provision, and clinical operations support across the full drug development lifecycle.
Cooperation possibilities
We collaborate with small and mid sized pharma and biotech across the full clinical research lifecycle, offering CRO services, clinical trial consultancy, functional service provision, and trial management. From biotech research to drug development, we deliver cost-effective, expert-led solutions.
- https://accelsiors.com/
- +41 43 508 72 37
- Send an email
- István Horváth
Some insights
We help bring safer, more effective medicines to patients faster by enabling efficient, ethical, and high-quality clinical research worldwide. By supporting biopharma innovation and rigorous trial execution, we contribute to better healthcare outcomes globally, with patient centricity at core.
We’re proud of our role in advancing life-changing therapies through trusted partnerships, scientific integrity, and operational excellence. Our team’s expertise, global reach, and commitment to quality help sponsors navigate complex clinical development with clarity and confidence.
Our team combines deep scientific, regulatory, and clinical operations expertise with global trial delivery experience. Going forward, we aim to strengthen capabilities in data science, digital clinical technologies, real-world evidence, and AI-enabled trial optimisation.
Through strategic partnerships, early engagement with biotech innovators, and collaboration with Swiss research institutions. Support via networking, pilot projects, and access to talent and funding would help accelerate high-quality clinical development from Switzerland to global markets.
We'd like to connect with biotech and pharmaceutical decision makers regarding possible cooperation in the field of clinical trials and clinical research.
